3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Treatment of Venous Thromboembolism in Cancer Patients
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
Cyclophosphamide
29
fludarabine phosphate
27
Mycophenolic Acid
21
Peripheral Blood Stem Cell Transplantation
18
Whole-Body Irradiation
17
Cyclosporine
16
Busulfan
15
Tacrolimus
14
Antilymphocyte Serum
12
Melphalan
11
Filgrastim
11
fludarabine
10
Cord Blood Stem Cell Transplantation
10
Radiotherapy
7
Methotrexate
7
Methylprednisolone
6
Etoposide
6
Stem Cell Transplantation
4
Cytarabine
4
thymoglobulin
3
Thiotepa
3
Sirolimus
3
Hematopoietic Stem Cell Transplantation
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporins
3
Alemtuzumab
3
ruxolitinib
2
luspatercept
2
Specimen Handling
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
N(4)-oleylcytosine arabinoside
×
Classical hematology
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled